Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 1.01% | 296.83 | 1.4% | $601.48m | |
| AMGN | Amgen, Inc. | 0.32% | 236.74 | 1.3% | $495.31m | |
| GILD | Gilead Sciences, Inc. | -2.75% | 65.77 | 1.0% | $370.34m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.15% | 376.42 | 2.6% | $305.23m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.71% | 218.98 | 1.9% | $275.99m | |
| ILMN | Illumina, Inc. | 0.85% | 324.72 | 3.5% | $241.12m | |
| CLVS | Clovis Oncology, Inc. | -4.24% | 12.86 | 14.7% | $219.13m | |
| SRPT | Sarepta Therapeutics, Inc. | 31.43% | 132.05 | 14.6% | $207.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.82% | 110.42 | 2.0% | $199.61m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -1.28% | 66.46 | 11.4% | $199.52m | |
| A | Agilent Technologies, Inc. | -1.30% | 83.71 | 1.6% | $164.84m | |
| EXAS | EXACT Sciences Corp. | 2.08% | 87.20 | 24.0% | $164.17m | |
| BLUE | bluebird bio, Inc. | 6.78% | 89.75 | 14.2% | $152.73m | |
| GBT | Global Blood Therapeutics, Inc. | -0.01% | 76.88 | 6.0% | $140.08m | |
| BOLD | Audentes Therapeutics, Inc. | 0.05% | 59.40 | 1.4% | $136.27m |
Company Profile
ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.